Chemotherapy Conundrum - Hallo friendsLET'S HEALTHY LIFE, In the article you read this time with the title Chemotherapy Conundrum, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cough, Article diabetes, Article diseases, Article in general, Article Phytotherapy, Article skin diseases, We write this you can understand. Alright, good read.

Title : Chemotherapy Conundrum
link : Chemotherapy Conundrum

Chemotherapy Conundrum

Chemotherapy is usually effective against cancer, but recurrence/resistance can occur.  Senescence – stopping of cell cycle and cell growth – is typically considered good for malignant cancer cells, stop them from dividing as a therapy.  But here we see that chemotherapy-induced senescence changes cancer cells so that if they are released from senescence and re-enter cell cycle growth, they are more dangerous than before – with more stem cell like properties and more aggressive growth.  This needs to be addressed.  Abstract:

Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16INK4a, p21CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells

Thus Article Chemotherapy Conundrum

That's an article Chemotherapy Conundrum This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Chemotherapy Conundrum with the link address https://letslifes.blogspot.com/2018/04/chemotherapy-conundrum.html

Tweet

Subscribe to receive free email updates: